Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01610167 · ClinicalTrials.gov registry record · NA
NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study
A NA study, sponsored by Dentsply International.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT01610167 is a NA study that has completed, run by Dentsply International. The registered enrollment target is 151 participants.
The verdict
NCT01610167, a NA study, has completed, sponsored by Dentsply International.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.
Interventions
- DEVICE NUPRO Classic Prophy Paste
- DEVICE NUPRO Sensodyne Prophy Paste with Novamin with fluoride.
- DEVICE NUPRO Sensodyne Prophy Paste with Novamin without fluoride.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01610167
The ClinicalTrials.gov registry entry for NCT01610167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dentsply International, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which NUPRO Classic Prophy Paste is the first listed.
NCT01610167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01610167 about?
NCT01610167 is a clinical study titled "NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study". The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.
What is the current status of trial NCT01610167?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2011-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01610167?
The interventions under investigation include: NUPRO Classic Prophy Paste (DEVICE), NUPRO Sensodyne Prophy Paste with Novamin with fluoride. (DEVICE), NUPRO Sensodyne Prophy Paste with Novamin without fluoride. (DEVICE).
Who is sponsoring clinical trial NCT01610167?
This trial is sponsored by Dentsply International, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.